A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS

Journal of Analytical Toxicology

Volumn 28, Issue 6, 2004, Pages 407-410

  Vorce, Shawn P ^a   Sklerov, Jason H ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIMETHYL 4 N PROPYLTHIO BETA PHENETHYLAMINE; 4 BROMO 2,5 DIMETHOXY BETA PHENETHYLAMINE; DESIGNER DRUG; HYDROXYAMPHETAMINE; N,N DIISOPROPYL 5 METHOXYTRYPTAMINE; N,N DIMETHYLTRYPTAMINE; N,N DIPROPYLTRYPTAMINE; PHENETHYLAMINE DERIVATIVE; PROPIONIC ACID DERIVATIVE; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

BLOOD LEVEL; CONFERENCE PAPER; DRUG ABUSE; DRUG SCREENING; ELECTROSPRAY MASS SPECTROMETRY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; URINE LEVEL;

EID: 4344659962     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.6.407     Document Type: Conference Paper

References (13)

1. U.S. Drug Enforcement Administration. Microgram Bull. 36(8): Aug. (2003).
2. U.S. Drug Enforcement Administration. Microgram Bull. 37(1): Jan. (2004).
3. Drug Enforcement Administration (DEA), Department of Justice. Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule. Fed. Regist. 68(65): 16427-16430 (2003).
4. U.S. Drug Enforcement Administration. Microgram Bull. 34(10): Aug. (2001).
5. A. Shulgin and A. Shulgin. TIHKAL the Continuation. Transform Press, Berkeley, CA, 1997, pp 527-531.
6. G.K Aghajanian and G.J. Marek. Serotonin and psychedelics. Neuropsychopharmacology 21: 16S-23S (1999).
7. N.M. Barnes and T. Sharp. A review of central 5-HT receptors and their functions. Neuropharmacology 38: 1083-1152 (1999).
8. R. Meatherall and P. Sharma. Foxy, a designer tryptamine hallucinogen. J. Anal. Toxicol. 27: 313-317 (2003).
9. A.T. Shulgin and M.F Carter. N,N-Diisopropyltryptamine (DiPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT). Two orally active tryptamine analogues with CNS activity. Comm. Psychopharmacol. 4: 363-369 (1980).
10. Clean screen® extraction columns application manual. United Chemical Technologies, Inc., Bristol, PA. Revision number 691070.
11. S. Szara. 6-Hydroxylation: an important metabolic route for alpha-methyltryptamine. Experientia 17: 76-77 (1961).
12. B.R. Sitaram, L. Lockett, G.L. Blackman, and W.R. McLeod. Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat. Biochem. Pharmacol. 36: 2235-2237 (1987).
13. S.A. Barker, J.M. Beaton, S.T. Christian, J.A. Monti, and P.E. Morris. In vivo metabolism of tetradeutero N,N-dimethyltryptamine in rodent brain. Biochem. Pharmacol. 33: 1395-1400 (1984).